1
|
Ong KJ, Johnston J, Datar I, Sewalt V, Holmes D, Shatkin JA. Food safety considerations and research priorities for the cultured meat and seafood industry. Compr Rev Food Sci Food Saf 2021; 20:5421-5448. [PMID: 34633147 DOI: 10.1111/1541-4337.12853] [Citation(s) in RCA: 48] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2021] [Revised: 08/31/2021] [Accepted: 09/04/2021] [Indexed: 12/14/2022]
Abstract
Cell-cultured meat and seafood offer a sustainable opportunity to meet the world's increasing demand for protein in a climate-changed world. A responsible, data-driven approach to assess and demonstrate safety of cell-cultured meat and seafood can support consumer acceptance and help fully realize the potential of these products. As an initial step toward a thorough demonstration of safety, this review identifies hazards that could be introduced during manufacturing, evaluates applicability of existing safety assessment approaches, and highlights research priorities that could support safe commercialization. Input was gathered from members of the cultured meat and seafood industry, researchers, regulators, and food safety experts. A series of workshops were held with 87 industry representatives and researchers to create a modular manufacturing process diagram, which served as a framework to identify potential chemical and biological hazards along the steps of the manufacturing process that could affect the safety of a final food product. Interviews and feedback on draft documents validated the process diagram and supported hazard identification and evaluation of applicable safety methods. Most hazards are not expected to be novel; therefore, safety assessment methods from a range of fields, such as conventional and novel foods, foods produced from biotechnology, pharmaceuticals, and so forth, are likely to be applicable. However, additional assessment of novel inputs or products with significant differences from existing foods may be necessary. Further research on the safety of the inputs and associated residues, potential for contamination, and development of standardized safety assessment approaches (particularly animal-free methods) is recommended.
Collapse
Affiliation(s)
| | | | - Isha Datar
- New Harvest Inc., Cambridge, Massachusetts, USA
| | | | | | | |
Collapse
|
2
|
Hu Y, Guo M, Zhuo Q, Han C, Shi L, Mao H, Li Y, Zhao J, Chen C, Yang X. Three-Generation Reproductive Toxicity of Genetically Modified Maize with Cry1Ab and epsps Genes in Rats. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2020; 68:10912-10919. [PMID: 32649186 DOI: 10.1021/acs.jafc.0c02237] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
The genetically modified maize carrying an insect-resistant gene and herbicide-tolerant gene has substantial benefits for crop production. The three-generation reproductive toxicity of the maize was studied in this paper. One hundred and eighty Sprague-Dawley (SD) rats were divided into three groups, which were fed with a genetically modified maize (GM) diet, receptor maize (RM) diet, and AIN-93G (AIN) diet (used as control), respectively. The body weight, food consumption, reproductive parameters, hematological parameters, serum chemistry, organ weight, and histopathology for the three generations were examined, respectively. Minor differences were found between the GM group and the RM group or the AIN control group in terms of reproductive data, hematology, blood chemistry parameters, and organ index, but no macroscopic or histological adverse effects were found or considered as treatment-related. In conclusion, the three-generation study of genetically modified maize DBN9936 with Cry1Ab and epsps genes at a high level showed no unintended adverse effects on rats' reproductive system.
Collapse
Affiliation(s)
- Yichun Hu
- Key Laboratory of Trace Element Nutrition of National Health Commission, National Institute for Nutrition, China CDC, Beijing 100050, PR China
| | - Mengfan Guo
- Key Laboratory of Trace Element Nutrition of National Health Commission, National Institute for Nutrition, China CDC, Beijing 100050, PR China
- Health Supervision Institute of Dongcheng District, Beijing 100027, PR China
| | - Qin Zhuo
- Key Laboratory of Trace Element Nutrition of National Health Commission, National Institute for Nutrition, China CDC, Beijing 100050, PR China
| | - Chao Han
- Key Laboratory of Trace Element Nutrition of National Health Commission, National Institute for Nutrition, China CDC, Beijing 100050, PR China
| | - Lili Shi
- Key Laboratory of Trace Element Nutrition of National Health Commission, National Institute for Nutrition, China CDC, Beijing 100050, PR China
| | - Hongmei Mao
- Key Laboratory of Trace Element Nutrition of National Health Commission, National Institute for Nutrition, China CDC, Beijing 100050, PR China
| | - Yan Li
- Key Laboratory of Trace Element Nutrition of National Health Commission, National Institute for Nutrition, China CDC, Beijing 100050, PR China
| | - Jinpeng Zhao
- Key Laboratory of Trace Element Nutrition of National Health Commission, National Institute for Nutrition, China CDC, Beijing 100050, PR China
| | - Chen Chen
- Key Laboratory of Trace Element Nutrition of National Health Commission, National Institute for Nutrition, China CDC, Beijing 100050, PR China
| | - Xiaoguang Yang
- Key Laboratory of Trace Element Nutrition of National Health Commission, National Institute for Nutrition, China CDC, Beijing 100050, PR China
| |
Collapse
|
3
|
Arpaia S, Christiaens O, Giddings K, Jones H, Mezzetti B, Moronta-Barrios F, Perry JN, Sweet JB, Taning CNT, Smagghe G, Dietz-Pfeilstetter A. Biosafety of GM Crop Plants Expressing dsRNA: Data Requirements and EU Regulatory Considerations. FRONTIERS IN PLANT SCIENCE 2020; 11:940. [PMID: 32670333 PMCID: PMC7327110 DOI: 10.3389/fpls.2020.00940] [Citation(s) in RCA: 39] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/30/2020] [Accepted: 06/09/2020] [Indexed: 05/16/2023]
Abstract
The use of RNA interference (RNAi) enables the silencing of target genes in plants or plant-dwelling organisms, through the production of double stranded RNA (dsRNA) resulting in altered plant characteristics. Expression of properly synthesized dsRNAs in plants can lead to improved crop quality characteristics or exploit new mechanisms with activity against plant pests and pathogens. Genetically modified (GM) crops exhibiting resistance to viruses or insects via expression of dsRNA have received authorization for cultivation outside Europe. Some products derived from RNAi plants have received a favourable opinion from the European Food Safety Authority (EFSA) for import and processing in the European Union (EU). The authorization process in the EU requires applicants to produce a risk assessment considering food/feed and environmental safety aspects of living organisms or their derived food and feed products. The present paper discusses the main aspects of the safety assessment (comparative assessment, molecular characterization, toxicological assessment, nutritional assessment, gene transfer, interaction with target and non-target organisms) for GM plants expressing dsRNA, according to the guidelines of EFSA. Food/feed safety assessment of products from RNAi plants is expected to be simplified, in the light of the consideration that no novel proteins are produced. Therefore, some of the data requirements for risk assessment do not apply to these cases, and the comparative compositional analysis becomes the main source of evidence for food/feed safety of RNAi plants. During environmental risk assessment, the analysis of dsRNA expression levels of the GM trait, and the data concerning the observable effects on non-target organisms (NTO) will provide the necessary evidence for ensuring safety of species exposed to RNAi plants. Bioinformatics may provide support to risk assessment by selecting target gene sequences with low similarity to the genome of NTOs possibly exposed to dsRNA. The analysis of these topics in risk assessment indicates that the science-based regulatory process in Europe is considered to be applicable to GM RNAi plants, therefore the evaluation of their safety can be effectively conducted without further modifications. Outcomes from the present paper offer suggestions for consideration in future updates of the EFSA Guidance documents on risk assessment of GM organisms.
Collapse
Affiliation(s)
- Salvatore Arpaia
- ENEA, Italian National Agency for New Technologies, Energy and Sustainable Economic Development, Rotondella, Italy
| | - Olivier Christiaens
- Department of Plants and Crops, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium
| | - Kara Giddings
- Bayer, Crop Science R&D Regulatory Science, Chesterfield, MO, United States
| | - Huw Jones
- Translational Genomics for Plant Breeding, Aberystwyth University, Wales, United Kingdom
| | - Bruno Mezzetti
- Department of Agricultural, Food and Environmental Sciences, Università Politecnica delle Marche, Ancona, Italy
| | | | | | | | - Clauvis N. T. Taning
- Department of Plants and Crops, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium
| | - Guy Smagghe
- Department of Plants and Crops, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium
| | - Antje Dietz-Pfeilstetter
- Institute for Biosafety in Plant Biotechnology, Julius Kühn-Institut, Federal Research Centre for Cultivated Plants, Braunschweig, Germany
| |
Collapse
|